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Intrathecal (i.th.) (by direct lumbar puncture) and intraperitoneal (i.p.) administration of morphine (30-100/~g/rat) 
caused a dose-related inhibition of gastrointestinal transit in the rat. Pretreatment with i.th. naloxone (5/tg at - 5 min) 
reversed the effects of i.th., but not i.p., morphine. These results suggest that the spinal cord appears to be a target site 
for the inhibitory effects of morphine on gastrointestinal transit in the rat. 
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1. Introduction 
The brain (Burks, 1978) and spinal cord (Por- 
reca and Burks, 1983) have been recognized as 
independent target sites for centrally acting drugs 
which influence gastrointestinal function. Central, 
as well as peripheral, administration of opioids can 
inhibit gastrointestinal transit (Green, 1959; 
Stewart et al., 1978). Intrathecal (i.th.) injection of 
morphine in mice, by direct lumbar puncture, re- 
sults in a dose-dependent, naloxone-reversible in- 
hibition of gastrointestinal transit (Porreca et al., 
1983). Surprisingly, however, i.th. administration 
of morphine to rats was not effective in slowing 
gastrointestinal transit, suggesting the existence of 
a species difference between mice and rats in this 
endpoint (Vaught et al., 1983). In the latter study, 
the drug was delivered to the spinal subarachnoid 
space by means of a surgically implanted cannula 
as described by Yaksh and Rudy (1976). Results 
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using this technique have occasionally been dif- 
ficult to explain. For example, Herman and Gold- 
stein (1985), using the i.th. cannula technique, 
reported that dynorphin A is a more potent 
analgesic when given within 1 day of i.th. cannu- 
lation as opposed to 7 days post-surgery. Thus, it 
is possible that the method of drug delivery (i.e. 
i.th. cannula vs. direct lumbar puncture) is re- 
sponsible for the divergent results seen with the 
morphine antitransit effects in mice and rats. In 
the present work, we determined whether i.th. 
morphine, delivered by direct lumbar puncture to 
rats could affect gastrointestinal transit. Addition- 
ally, the possibility of i.th. morphine leaking out of 
the spinal subarachnoid space and affecting the 
gut at peripheral sites was examined using i.th. 
naloxone. We now report that morphine is active 
at spinal sites in slowing gut transit in the rat 
when it is given by direct lumbar puncture. 
2. Materials and methods 
Male, Sprague Dawley rats (Charles River, 60-80 
g) were starved overnight prior to experimentation. 
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W a t e r  was avai lable  ad l ibi tum. Test ing consis ted 
of  i.th. p re t r ea tmen t  with ei ther saline or na loxone  
(5 /*g / ra t )  (Sigma) given 5 rain pr ior  to the injec- 
t ion of test c o m p o u n d  (morph ine  or saline). The 
test c o m p o u n d  was given by ei ther  i.th. or  i.p. 
routes:  i.th. inject ions were made  by direct  l umbar  
punc ture  between the fifth and sixth lumbar  
ver tebrae  in unanes the t i sed  rats  as descr ibed  by 
Hylden  and Wilcox (1980). A cons tan t  5/*1 volume 
was employed  and del ivered using a Hami l ton  
microl i ter  syringe fi t ted with a 30 gauge needle. 
I.p. inject ions were made  using a cons tant  0.5 ml 
volume.  The response at each dose was de te rmined  
using 8-12 rats. 
Gas t ro in tes t ina l  t ransi t  was measured  by the 
me thod  descr ibed  by Porreca and Burks (1983). 
Immed ia t e ly  fol lowing inject ion of test compound ,  
rats received an oral inject ion of 5~Cr as sodium 
ch romate  in saline (0.5 /*Ci, 0.2 m l / r a t )  (New 
England  Nuclear) .  Thir ty-f ive minutes  af ter  ad- 
min i s t ra t ion  of -S~Cr, the animal  was kil led by 
cervical  dis locat ion,  and the s tomach and small  
intest ine removed.  The small  bowel was then p laced  
on a ruled t empla te  and d iv ided  into 10 segments  
of  equal  length. Each of  the 10 pieces, plus the 
s tomach,  were p laced  into individual  and consecu-  
tive vials. Rad ioac t iv i ty  was de te rmined  for each 
vial by g a m m a  count ing  for 1 min. Trans i t  was 
ca lcula ted  by the geometr ic  center  method  (Mil ler  
et al., 1980). Values range from 1.0 to 10, with a 
lower numer ic  value ind ica t ing  slower t ransi t  of 
the radioac t ive  marker .  Trans i t  da ta  were sub- 
jec ted  to analysis  of  variance,  and  where signifi- 
cance was indicated,  fol lowed by Student ' s  t-test 
for unpa i red  data.  
3. Results 
I.th. a d m i n i s t r a t i o n  of m o r p h i n e  (30-100 
/*g / ra t )  had  a marked  dose- re la ted  inh ib i tory  ef- 
fect on gas t ro in tes t ina l  t ransi t  (fig. 1). An  ex- 
amina t ion  of poss ible  per iphera l  gut effects of  
morph ine  by  i.p. drug admin i s t r a t ion  showed a 
significant ,  but  less p ronounced ,  effect over a simi- 
lar dose range (fig. 2). In order  to de te rmine  if the 
effects of i.th. morph ine  were occurr ing at the 
spinal  level, the exper iments  were repeated  in 
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Fig. I. Dose-response relationship for i.th. morphine inhibition 
of gastrointestinal transit in the rat. Graded doses of morphine 
were given concurrently with oral sodium chromate/saline and 
transit was measured at + 35 min. The effect of i.th. naloxone 
(5 /*g at - 5  min) is shown in the 2 bars on the right. 
an imals  p re t r ea ted  with na loxone  (5 /*g at 5 
min). I.th. na loxone  blocked the inhibi tory  t ransi t  
effects of a sub threshold  dose of  i.th. morph ine  (80 
/*g / ra t )  (fig. 1), whereas the same i.p. morph ine  
dose ( 8 0 / , g / r a t )  was still effective in slowing gut 
t ransi t  (fig. 2) in na loxone  pre t rea ted  animals.  
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Fig. 2. Dose-response relationship for i.p. morphine inhibition 
of gastrointestinal transit in the rat. Graded doses of morphine 
were given 20 min prior to oral sodium chromate/saline and 
transit measured after a further 35 min. The effect of i.th. 
naloxone (5 >g at - 5  min) is shown in the 2 bars on the right. 
4. Discussion 
Opioids can affect gastrointestinal transit by 
both central and peripheral sites of action (Green, 
1959; Stewart et al., 1978). Porreca et al. (1983) 
demonstrated that morphine injected i.th. in mice 
Caused inhibition of gut transit, a result confirmed 
by Vaught et al. (1983). Morphine can, therefore, 
act independently at spinal or supraspinal sites to 
slow gastrointestinal transit in the mouse (Porreca 
and Burks, 1983). Our previous results had in- 
dicated that while i.th. morphine in rats caused 
analgesia, antitransit effects could not be demon- 
strated (Vaught et al., 1983). This result was 
surprising in light of the results in the mouse, as 
well as the effectiveness of i.th. bombesin in slow- 
ing gut transit when delivered by the same 
technique (Gmerek et al., 1983). 
Herman and Goldstein (1985) have recently 
demonstrated that chronic i.th. cannulation using 
the Yaksh and Rudy technique (1976) can affect 
the analgesic potency of opioid peptides such as 
dynorphin A. With analgesia as the endpoint, dy- 
norphin A was found to be equipotent to morphine 
when drug was injected within 1 day after cannula 
implantation. Seven days after surgery, however, 
dynorphin was an order of magnitude less potent 
than morphine (Herman and Goldstein, 1985). 
This study, together with the antitransit effective- 
ness of i.th. morphine given by direct lumbar 
puncture in the mouse, suggested that the method 
of drug delivery might be responsible for the lack 
of observable gut effects in our previous study 
employing the cannula technique for delivery of 
opioids (Vaught et al., 1983). Alternatively, the 
dose delivered in the previous work, while effective 
in producing analgesia, may not have been high 
enough in relation to the time following cannula- 
tion of the animals. A further possible difference 
between the previous and present results may re- 
late to the method employed for measuring transit. 
Vaught et al. (1983) used a charcoal meal technique 
(Green, 1959) while the present work employed a 
radiolabelled, liquid marker. While evidence exists 
regarding differential emptying of solids and 
liquids, this possibility seems remote in this case, 
as i.th. morphine by lumbar puncture is effective 
in slowing transit in the mouse when transit is 
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evaluated by either technique (unpublished results). 
In any case, results from the present study demon- 
strate unequivocally that, using a different means 
of i.th. drug delivery (direct lumbar puncture) 
morphine does inhibit gastrointestinal transit in 
rats. Morphine, given peripherally was also effec- 
tive of the same dose range (30-100/~g/rat). 
In order to determine if i.th. morphine was 
acting centrally or peripherally, rats were pre- 
treated with i.th. naloxone. Pretreatment with this 
antagonist eliminated the antitransit effects of 80 
/~g/rat of i.th., but not i.p., morphine. These data 
suggest, therefore, that i.th. morphine acts at spi- 
nal sites to initiate inhibition of gut transit in rats. 
In support of this finding, it should be noted that 
intracerebroventricular morphine also slows gut 
transit over exactly the same dose range (Porreca 
et al., 1982). 
In summary, we have demonstrated that i.th. 
morphine inhibits gastrointestinal transit in a 
dose-related fashion in rats. This effect is pre- 
vented by i.th. pretreatment with naloxone. There- 
fore, gut transit is slowed in both mice and rats in 
response to i.th. morphine. The reasons for the 
ineffectiveness of i.th. morphine after delivery by 
chronically implanted cannula are unclear. 
Surprisingly, this difference in effectiveness be- 
tween the 2 methods of drug delivery does not 
apply to bombesin, a peptide which also slows gut 
transit, as this agent is effective in rats by either 
technique (Gmerek et al., 1983; Kosla and Por- 
reca, unpublished observations). Further experi- 
mentation will be necessary to determine if species 
differences exist with other opiates or opioid 
peptides. 
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